{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:40Z","timestamp":1792098580671,"version":"4.4.0"},"reference-count":182,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL118390"],"award-info":[{"award-number":["HL118390"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007698"],"award-info":[{"award-number":["T32HL007698"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["1I01BX00192"],"award-info":[{"award-number":["1I01BX00192"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01348","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T12:59:10Z","timestamp":1560517150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":155,"title":["Fibrinolysis and Inflammation in Venous Thrombus Resolution"],"prefix":"10.3389","volume":"10","author":[{"given":"Subhradip","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tierra A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadire","family":"Duru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite S.","family":"Buzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajabrata","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni M.","family":"Antalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/jth.12698","article-title":"Thrombosis: a major contributor to the global disease burden.","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signaling in cardiac ischemia.","volume":"8","author":"Arslan","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/ATVBAHA.110.213157","article-title":"Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms.","volume":"31","author":"Swedenborg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis.","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrcardio.2017.52","article-title":"Monocytes and macrophages in abdominal aortic aneurysm.","volume":"14","author":"Raffort","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women.","volume":"350","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study.","volume":"5","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/JBM.S19009","article-title":"Deep vein thrombosis: a clinical review.","volume":"2","author":"Kesieme","year":"2011","journal-title":"J Blood Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/heart.85.2.229","article-title":"Acute pulmonary embolism 1: pathophysiology, clinical presentation, and diagnosis.","volume":"85","author":"Riedel","year":"2001","journal-title":"Heart"},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.","volume":"209","author":"von Bruhl","year":"2012","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(05)71880-8","article-title":"Deep vein thrombosis.","volume":"365","author":"Kyrle","year":"2005","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s004390100593","article-title":"Genetic risk factors of venous thrombosis.","volume":"109","author":"Franco","year":"2001","journal-title":"Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","article-title":"Endothelial cell control of thrombosis.","volume":"15","author":"Yau","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jvs.2007.03.009","article-title":"Sonographic elasticity imaging of acute and chronic deep venous thrombosis in humans.","volume":"25","author":"Rubin","year":"2006","journal-title":"J Ultrasound Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/5584_2016_116","article-title":"Endovascular treatment of thrombosis and embolism.","volume":"906","author":"Goktay","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B18","first-page":"770","article-title":"Systemic thrombolysis for pulmonary embolism: a review.","volume":"41","author":"Martin","year":"2016","journal-title":"P T"},{"key":"B19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2141.2009.07601.x","article-title":"Post-thrombotic syndrome: prevalence, prognostication and need for progress.","volume":"145","author":"Prandoni","year":"2009","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/asheducation-2010.1.216","article-title":"The post-thrombotic syndrome.","volume":"2010","author":"Kahn","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"B21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/jth.12180","article-title":"Post-thrombotic syndrome: a clinical review.","volume":"11","author":"Baldwin","year":"2013","journal-title":"J Thromb Haemost"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1182\/blood-2009-07-199174","article-title":"How I treat postthrombotic syndrome.","volume":"114","author":"Kahn","year":"2009","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1067\/mva.2002.121066","article-title":"Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis.","volume":"35","author":"Meissner","year":"2002","journal-title":"J Vasc Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/s-0032-1302447","article-title":"Multifaceted management of the postthrombotic syndrome.","volume":"29","author":"Nayak","year":"2012","journal-title":"Semin Intervent Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1160\/TH08-08-0511","article-title":"Levels of inflammatory markers and the development of the post-thrombotic syndrome.","volume":"101","author":"Shbaklo","year":"2009","journal-title":"Thromb Haemost"},{"key":"B26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0741-5214(89)90223-1","article-title":"Spontaneous lysis of deep venous thrombi: rate and outcome.","volume":"9","author":"Killewich","year":"1989","journal-title":"J Vasc Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1538-7836.2004.01106.x","article-title":"Vein abnormalities and the post-thrombotic syndrome.","volume":"3","author":"Prandoni","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1160\/TH13-06-0442","article-title":"Residual vein thrombosis and trans-popliteal reflux in patients with and without the post-thrombotic syndrome.","volume":"110","author":"Vedovetto","year":"2013","journal-title":"Thromb Haemost"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.13793","article-title":"Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes.","volume":"15","author":"Chandrashekar","year":"2017","journal-title":"J Thromb Haemost"},{"key":"B30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/0741-5214(93)90069-X","article-title":"Deep venous insufficiency: the relationship between lysis and subsequent reflux.","volume":"18","author":"Meissner","year":"1993","journal-title":"J Vasc Surg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10016-004-0133-3","article-title":"Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux.","volume":"19","author":"Singh","year":"2005","journal-title":"Ann Vasc Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s003950070028","article-title":"Mouse models of focal arterial and venous thrombosis.","volume":"95","author":"Dorffler-Melly","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1055\/s-2007-985758","article-title":"Transgenic mouse models of venous thrombosis: fulfilling the expectations?","volume":"33","author":"Cleuren","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"B34","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/ATVBAHA.111.244608","article-title":"Critical review of mouse models of venous thrombosis.","volume":"32","author":"Diaz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/ATVBAHA.112.246173","article-title":"Mouse models, risk factors, and treatments of venous thrombosis.","volume":"32","author":"Mackman","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1182\/blood-2016-03-704270","article-title":"Mouse models of venous thrombosis are not equal.","volume":"127","author":"Mackman","year":"2016","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jth.14413","article-title":"Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application.","volume":"17","author":"Diaz","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1055\/s-0037-1613739","article-title":"Murine thrombosis models.","volume":"92","author":"Day","year":"2004","journal-title":"Thromb Haemost"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/j.jbiomech.2010.07.012","article-title":"A biomechanical analysis of venous tissue in its normal and post-phlebitic conditions.","volume":"43","author":"McGilvray","year":"2010","journal-title":"J Biomech"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139145","article-title":"Matrix metalloproteinase 9 (MMP-9) regulates vein wall biomechanics in murine thrombus resolution.","volume-title":"PLoS ONE. (","author":"Nguyen","year":""},{"key":"B41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/ATVBAHA.110.213405","article-title":"Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.","volume":"31","author":"Saha","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.4049\/jimmunol.177.5.3388","article-title":"Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model.","volume":"177","author":"Henke","year":"2006","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1172\/JCI40782","article-title":"Absence of IFN-gamma accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice.","volume":"121","author":"Nosaka","year":"2011","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.3791\/2738","article-title":"Mouse complete stasis model of inferior vena cava thrombosis.","volume-title":"J Vis Exp","author":"Wrobleski","year":"2011"},{"key":"B45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jth.12424","article-title":"Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction.","volume":"12","author":"Gabre","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jth.12657","article-title":"Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.","volume":"12","author":"Siefert","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood-2016-07-727180","article-title":"Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice.","volume":"129","author":"Mukhopadhyay","year":"2017","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-8645-3_13","article-title":"Serpins in venous thrombosis and venous thrombus resolution.","volume":"1826","author":"Mukhopadhyay","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1001\/archinte.1993.00410240085010","article-title":"Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound.","volume":"153","author":"Cogo","year":"1993","journal-title":"Arch Intern Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","article-title":"von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models.","volume":"117","author":"Brill","year":"2011","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice.","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.3791\/56697","article-title":"Stenosis of the inferior vena cava: a murine model of deep vein thrombosis.","volume-title":"J Vis Exp.","author":"Payne","year":"2017"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2016-09-742999","article-title":"Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.","volume":"129","author":"Payne","year":"2017","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1182\/blood.V99.9.3235","article-title":"Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model.","volume":"99","author":"Singh","year":"2002","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/01.CIR.0000050149.22928.39","article-title":"Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.","volume":"107","author":"Singh","year":"2003","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1538-7836.2006.01703.x","article-title":"Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.","volume":"4","author":"Wang","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1160\/TH12-09-0711","article-title":"The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.","volume":"109","author":"Diaz","year":"2013","journal-title":"Thromb Haemost"},{"key":"B58","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/blood.V71.3.728.728","article-title":"A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice.","volume":"71","author":"Kumada","year":"1988","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0038-1648156","article-title":"Antithrombotic activity of a novel C-terminal hirudin analog in experimental animals.","volume":"65","author":"Broersma","year":"1991","journal-title":"Thromb Haemost"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1182\/blood-2002-05-1470","article-title":"Protection against thrombosis in mice lacking PAR3.","volume":"100","author":"Weiss","year":"2002","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1182\/blood.V98.4.1055","article-title":"Variable protection of \u03b23-integrin\u2013deficient mice from thrombosis initiated by different mechanisms.","volume":"98","author":"Smyth","year":"2001","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1046\/j.1538-7836.2003.00252.x","article-title":"Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.","volume":"1","author":"Matsuno","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jth.13182","article-title":"Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.","volume":"14","author":"Shaya","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2009-03-209981","article-title":"Valves of the deep venous system: an overlooked risk factor.","volume":"114","author":"Brooks","year":"2009","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1259\/0007-1285-44-525-653","article-title":"The origin of deep vein thrombosis: a venographic study.","volume":"44","author":"Nicolaides","year":"1971","journal-title":"Br J Radiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3400\/avd.oa.15-00088","article-title":"Clinical significance of the soleal vein and related drainage veins, in calf vein thrombosis in autopsy cases with massive pulmonary thromboembolism.","volume":"9","author":"Ro","year":"2016","journal-title":"Ann Vasc Dis"},{"key":"B67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jcp.27.7.517","article-title":"The structure and growth of valve-pocket thrombi in femoral veins.","volume":"27","author":"Sevitt","year":"1974","journal-title":"J Clin Pathol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"26002","DOI":"10.1074\/jbc.M002823200","article-title":"Binding sites of leukocyte beta 2 integrins (LFA-1, Mac-1) on the human ICAM-4\/LW blood group protein.","volume":"275","author":"Hermand","year":"2000","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1074\/jbc.M211282200","article-title":"Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin.","volume":"278","author":"Hermand","year":"2003","journal-title":"J Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2012-11-468983","article-title":"Red blood cells mediate the onset of thrombosis in the ferric chloride murine model.","volume":"121","author":"Barr","year":"2013","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1111\/j.1538-7836.2003.0543b.x","article-title":"High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly.","volume":"1","author":"van Hylckama Vlieg","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1182\/blood-2010-11-316885","article-title":"Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.","volume":"117","author":"Machlus","year":"2011","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000452864","article-title":"Thrombosis in inherited fibrinogen disorders.","volume":"44","author":"Korte","year":"2017","journal-title":"Transfus Med Hemother"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives.","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"B76","first-page":"S72","article-title":"Thrombus resolution and vein wall injury: dependence on chemokines and leukocytes.","volume-title":"Thromb Res.","author":"Henke","year":"2009"},{"key":"B77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.forsciint.2009.12.008","article-title":"Time-dependent organic changes of intravenous thrombi in stasis-induced deep vein thrombosis model and its application to thrombus age determination.","volume":"195","author":"Nosaka","year":"2010","journal-title":"Forensic Sci Int"},{"key":"B78","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/qjmed\/hcl070","article-title":"The aetiology of deep venous thrombosis.","volume":"99","author":"Malone","year":"2006","journal-title":"QJM"},{"key":"B79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00414-009-0324-0","article-title":"Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determination.","volume":"123","author":"Nosaka","year":"2009","journal-title":"Int J Legal Med"},{"key":"B80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0049-3848(89)90375-7","article-title":"Fibrinolytic activity of normal human blood monocytes.","volume":"53","author":"Grau","year":"1989","journal-title":"Thromb Res"},{"key":"B81","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00001721-199512000-00001","article-title":"Role of neutrophil membrane proteases in fibrin degradation.","volume":"6","author":"Adams","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1189\/jlb.0306152","article-title":"Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases.","volume":"80","author":"Webster","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"20262","DOI":"10.1073\/pnas.0706438104","article-title":"Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.","volume":"104","author":"Ardi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/ATVBAHA.108.162289","article-title":"Mechanisms of venous thrombosis and resolution.","volume":"28","author":"Wakefield","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1056\/NEJMoa054444","article-title":"D-dimer testing to determine the duration of anticoagulation therapy.","volume":"355","author":"Palareti","year":"2006","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/ATVBAHA.112.251983","article-title":"Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging.","volume":"32","author":"Ripplinger","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1083\/jcb.201301081","article-title":"M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway.","volume":"202","author":"Madsen","year":"2013","journal-title":"J Cell Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1749-6632.1964.tb52558.x","article-title":"Substances promoting leukocyte emigration.","volume":"116","author":"Hurley","year":"1964","journal-title":"Ann N Y Acad Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1084\/jem.138.3.686","article-title":"Role of the clotting system in cell-mediated hypersensitivity. I Fibrin deposition in delayed skin reactions in man.","volume":"138","author":"Colvin","year":"1973","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.4049\/jimmunol.150.7.2972","article-title":"Integrin regulation of leukocyte inflammatory functions. CD11b\/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes.","volume":"150","author":"Fan","year":"1993","journal-title":"J Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1160\/TH07-01-0039","article-title":"Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells.","volume":"97","author":"Jensen","year":"2007","journal-title":"Thromb Haemost"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.","volume":"167","author":"Smiley","year":"2001","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1084\/jem.20061931","article-title":"The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.","volume":"204","author":"Adams","year":"2007","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V90.9.3595","article-title":"Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells.","volume":"90","author":"Qi","year":"1997","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0092-8674(93)90367-Y","article-title":"Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway.","volume":"73","author":"Languino","year":"1993","journal-title":"Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1073\/pnas.0303859101","article-title":"Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.","volume":"101","author":"Akassoglou","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B97","first-page":"917","article-title":"Matrix metalloproteinase-1 and\u22129 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.","volume-title":"J Cell Sci.","author":"Davis","year":"2001"},{"key":"B98","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jcp.10126","article-title":"Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.","volume":"192","author":"Monea","year":"2002","journal-title":"J Cell Physiol"},{"key":"B99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017229","article-title":"Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature.","volume-title":"PLoS ONE. (","author":"Reichel","year":""},{"key":"B100","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jvs.2012.02.054","article-title":"The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.","volume":"56","author":"Baldwin","year":"2012","journal-title":"J Vasc Surg"},{"key":"B101","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation.","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"key":"B102","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis.","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","article-title":"D-dimer antigen: current concepts and future prospects.","volume":"113","author":"Adam","year":"2009","journal-title":"Blood"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jama.290.8.1071","article-title":"D-dimer levels and risk of recurrent venous thromboembolism.","volume":"290","author":"Eichinger","year":"2003","journal-title":"JAMA"},{"key":"B105","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/S0021-9258(18)95967-3","article-title":"The peptide chains of human plasmin.","volume":"242","author":"Robbins","year":"1967","journal-title":". J Biol Chem"},{"key":"B106","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0741-5214(97)70101-0","article-title":"Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement.","volume":"26","author":"Killewich","year":"1997","journal-title":"J Vasc Surg"},{"key":"B107","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology.","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/01.ATV.0000189309.05924.88","article-title":"Stimulated tissue plasminogen activator release as a marker of endothelial function in humans.","volume":"25","author":"Oliver","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B109","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator.","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"Role of fibrin. J Biol Chem"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jth.14157","article-title":"Regulation of plasminogen activation on cell surfaces and fibrin.","volume":"16","author":"Urano","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B111","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/368419a0","article-title":"Physiological consequences of loss of plasminogen activator gene function in mice.","volume":"368","author":"Carmeliet","year":"1994","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jvs.2006.07.020","article-title":"Adenoviral urokinase-type plasminogen activator. (uPA) gene transfer enhances venous thrombus resolution.","volume":"44","author":"Gossage","year":"2006","journal-title":"J Vasc Surg"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jvs.2009.06.047","article-title":"Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.","volume":"50","author":"Humphries","year":"2009","journal-title":"J Vasc Surg"},{"key":"B114","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1021\/cr010170","article-title":"Serpin structure, mechanism, and function.","volume":"102","author":"Gettins","year":"2002","journal-title":"Chem Rev"},{"key":"B115","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0036-1585077","article-title":"alpha2-Antiplasmin: new insights and opportunities for ischemic stroke.","volume":"43","author":"Reed","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI116335","article-title":"Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.","volume":"91","author":"Weitz","year":"1993","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI110479","article-title":"Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.","volume":"69","author":"Sakata","year":"1982","journal-title":"J Clin Invest"},{"key":"B118","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-0038-1656372","article-title":"Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.","volume":"68","author":"Reed","year":"1992","journal-title":"Thromb Haemost"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1365-2516.2008.01766.x","article-title":"\u03b12-antiplasmin and its deficiency: fibrinolysis out of balance.","volume":"14","author":"Carpenter","year":"2008","journal-title":"Haemophilia"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1172\/JCI116893","article-title":"Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.","volume":"92","author":"Carmeliet","year":"1993","journal-title":"J Clin Invest."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2174\/1381612033454621","article-title":"Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.","volume":"9","author":"Stefansson","year":"2003","journal-title":"Curr Pharm Des"},{"key":"B122","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","article-title":"Platelets synthesize large amounts of active plasminogen activator inhibitor 1.","volume":"104","author":"Brogren","year":"2004","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0038-1648388","article-title":"The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility.","volume":"67","author":"Potter van Loon","year":"1992","journal-title":"Thromb Haemost."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bmj.290.6480.1453","article-title":"Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.","volume":"290","author":"Nilsson","year":"1985","journal-title":"Br Med J"},{"key":"B125","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1160\/TH04-12-0842","article-title":"Structure and function of the plasminogen\/plasmin system.","volume":"93","author":"Castellino","year":"2005","journal-title":"Thromb Haemost"},{"key":"B126","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nsb943","article-title":"How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.","volume":"10","author":"Zhou","year":"2003","journal-title":"Nat Struct Biol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1055\/s-0038-1650330","article-title":"The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism.","volume":"75","author":"Schulman","year":"1996","journal-title":"Thromb Haemost"},{"key":"B128","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/s-0037-1615594","article-title":"Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.","volume":"85","author":"Crowther","year":"2001","journal-title":"Thromb Haemost"},{"key":"B129","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/1076029609333673","article-title":"Plasminogen activator inhibitor-1 (PAI-1) gene 4G\/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.","volume":"16","author":"Akhter","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"B130","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1076029610361334","article-title":"Failure to lyse venous thrombi because of elevated plasminogen activator Inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1\/4G Syndrome).","volume":"16","author":"Bern","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"B131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13018-018-0716-2","article-title":"Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty.","volume":"13","author":"Tang","year":"2018","journal-title":"J Orthop Surg Res"},{"key":"B132","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0895-4356(03)00052-0","article-title":"Prospective study of fibrinolytic markers and venous thromboembolism.","volume":"56","author":"Folsom","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"B133","first-page":"S35","article-title":"Role of selectins and fibrinolysis in VTE.","volume-title":"Thromb Res.","author":"Wakefield","year":"2009"},{"key":"B134","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/346074a0","article-title":"Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.","volume":"346","author":"Erickson","year":"1990","journal-title":"Nature"},{"key":"B135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V95.2.577","article-title":"Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.","volume":"95","author":"Eitzman","year":"2000","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/j.1538-7836.2008.03063.x","article-title":"Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis.","volume":"6","author":"Hennan","year":"2008","journal-title":"J Thromb Haemost"},{"key":"B137","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1160\/TH09-09-0672","article-title":"Thrombogenesis with continuous blood flow in the inferior vena cava.","volume":"104","author":"Diaz","year":"2010","journal-title":". Thromb Haemost"},{"key":"B138","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jvs.2011.08.038","article-title":"Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.","volume":"55","author":"Diaz","year":"2012","journal-title":"J Vasc Surg"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/jth.12644","article-title":"Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.","volume":"12","author":"Obi","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1432-1033.1993.tb18467.x","article-title":"Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.","volume":"218","author":"Mikus","year":"1993","journal-title":"Eur J Biochem"},{"key":"B141","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-12-386471-0.00006-7","article-title":"Plasminogen activator inhibitor type 2: still an enigmatic serpin but a model for gene regulation.","volume":"499","author":"Medcalf","year":"2011","journal-title":"Methods Enzymol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/CritRevImmunol.v31.i1.20","article-title":"The role of SerpinB2 in immunity.","volume":"31","author":"Schroder","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"B143","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1016\/S0021-9258(18)68866-0","article-title":"Mammalian protein secretion without signal peptide removal.","volume":"263","author":"Ye","year":"1988","journal-title":"J Biol Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1365-3024.2010.01241.x","article-title":"SerpinB2 deficiency modulates Th1Th2 responses after schistosome infection.","volume":"32","author":"Schroder","year":"2010","journal-title":"Parasite Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.4049\/jimmunol.0902187","article-title":"A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity.","volume":"184","author":"Schroder","year":"2010","journal-title":"J Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1073\/pnas.96.2.686","article-title":"The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.","volume":"96","author":"Dougherty","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B147","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view.","volume":"5","author":"Ortega-Gomez","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI60229","article-title":"New insights into the mechanisms of venous thrombosis.","volume":"122","author":"Mackman","year":"2012","journal-title":"J Clin Invest"},{"key":"B149","first-page":"127","article-title":"Neutrophils and deep venous thrombosis.","volume-title":"Haemostasis.","author":"Stewart","year":"1993"},{"key":"B150","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1046\/j.1365-2141.2001.02696.x","article-title":"Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism.","volume":"113","author":"Moir","year":"2001","journal-title":"Br J Haematol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0741","article-title":"Neutropenia impairs venous thrombosis resolution in the rat.","volume":"38","author":"Varma","year":"2003","journal-title":"J Vasc Surg"},{"key":"B152","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jvs.2005.04.014","article-title":"Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.","volume":"42","author":"Deatrick","year":"2005","journal-title":"J Vasc Surg"},{"key":"B153","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1160\/TH05-02-0099","article-title":"Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization.","volume":"95","author":"Henke","year":"2006","journal-title":"Thromb Haemost"},{"key":"B154","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1160\/TH16-03-0218","article-title":"Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.","volume":"117","author":"Obi","year":"2017","journal-title":"Thromb Haemost"},{"key":"B155","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0741-5214(99)70014-5","article-title":"Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi.","volume":"30","author":"Humphries","year":"1999","journal-title":"J Vasc Surg"},{"key":"B156","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.thromres.2013.06.027","article-title":"Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT.","volume":"132","author":"Deatrick","year":"2013","journal-title":"Thromb Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/wound.2011.0307","article-title":"Regulation of macrophage polarization and wound healing.","volume":"1","author":"Ferrante","year":"2012","journal-title":"Adv Wound Care"},{"key":"B158","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jvsv.2016.03.005","article-title":"Alterations in macrophage phenotypes in experimental venous thrombosis.","volume":"4","author":"Gallagher","year":"2016","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.116.309301","article-title":"Innate effector-memory T-cell activation regulates post-thrombotic vein wall inflammation and thrombus resolution.","volume":"119","author":"Luther","year":"2016","journal-title":"Circ Res"},{"key":"B160","first-page":"306","article-title":"The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis.","volume":"26","author":"Poredos","year":"2007","journal-title":"Int Angiol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1160\/TH09-04-0274","article-title":"C-reactive protein and venous thromboembolism.","volume":"102","author":"Folsom","year":"2009","journal-title":". Thromb Haemost"},{"key":"B162","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.thromres.2011.04.016","article-title":"The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6\u2212174GC, IL-8\u2212251AT and MCP-1\u22122518AG in the risk of venous thromboembolism: a case-control study.","volume":"128","author":"Matos","year":"2011","journal-title":"Thromb Res"},{"key":"B163","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.3760\/cma.j.issn.0366-6999.2012.22.016","article-title":"Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.","volume":"125","author":"Mahemuti","year":"2012","journal-title":"Chin Med J"},{"key":"B164","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/0268355515607405","article-title":"The correlation analysis of tumor necrosis factor-alpha-308G\/A polymorphism and venous thromboembolism risk: a meta-analysis.","volume":"31","author":"Gao","year":"2016","journal-title":"Phlebology"},{"key":"B165","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fmed.2018.00147","article-title":"Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis.","volume":"5","author":"Mosevoll","year":"2018","journal-title":"Front Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.avsg.2010.09.003","article-title":"Interleukin-6: a potential target for post-thrombotic syndrome.","volume":"25","author":"Wojcik","year":"2011","journal-title":"Ann Vasc Surg"},{"key":"B167","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/ATVBAHA.118.311194","article-title":"Contribution of the TNF-alpha (Tumor Necrosis Factor-alpha)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) axis in the resolution of venous thrombus.","volume":"38","author":"Nosaka","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jvs.2005.10.073","article-title":"Monocyte recruitment in venous thrombus resolution.","volume":"43","author":"Ali","year":"2006","journal-title":"J Vasc Surg"},{"key":"B169","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1038\/s41598-018-21273-5","article-title":"Lack of T-bet reduces monocytic interleukin-12 formation and accelerates thrombus resolution in deep vein thrombosis.","volume":"8","author":"Schonfelder","year":"2018","journal-title":"Sci Rep"},{"key":"B170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116621","article-title":"Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring.","volume-title":"PLoS ONE. (","author":"Kessinger","year":""},{"key":"B171","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/ATVBAHA.110.216317","article-title":"Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.","volume":"31","author":"Henke","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B172","first-page":"1375","article-title":"The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2\/9 deletion in experimental post-thrombotic vein wall remodeling.","volume-title":"J Vasc Surg.","author":"Deatrick","year":"2013"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jvs.2008.07.050","article-title":"Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice.","volume":"48","author":"Bouzeghrane","year":"2008","journal-title":"J Vasc Surg."},{"key":"B174","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1160\/TH07-10-0608","article-title":"Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.","volume":"99","author":"Meier","year":"2008","journal-title":"Thromb Haemost"},{"key":"B175","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/ATVBAHA.114.304457","article-title":"P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.","volume":"35","author":"Diaz","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1160\/TH07-11-0669","article-title":"Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.","volume":"99","author":"Baxi","year":"2008","journal-title":"Thromb Haemost"},{"key":"B177","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis.","volume":"44","author":"Cushman","year":"2007","journal-title":"Semin Hematol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects.","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"195","DOI":"10.14797\/mdcj-12-4-195","article-title":"Epidemiology and pathophysiology of chronic thromboembolic pulmonary hypertension: risk factors and mechanisms.","volume":"12","author":"Medrek","year":"2016","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"B180","first-page":"S228","article-title":"Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.","volume-title":"Cardiovasc Diagn Ther.","author":"Fleck","year":"2017"},{"key":"B181","doi-asserted-by":"publisher","first-page":"219","DOI":"10.14797\/mdcj-14-3-219","article-title":"Pharmacologic and pharmacomechanical thrombolysis for acute deep vein thrombosis: focus on ATTRACT (CME).","volume":"14","author":"Comerota","year":"2018","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis.","volume":"377","author":"Vedantham","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01348\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T12:58:57Z","timestamp":1694955537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01348\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,14]]},"references-count":182,"alternative-id":["10.3389\/fimmu.2019.01348"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01348","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,14]]},"article-number":"1348"}}